Fig. 6. Hepatocellular carcinoma (HCC) recurrence and treatment, protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels and hepatitis B surface antigen (HBsAg) titers. HCC and hepatitis B recurrences showed similar trends. LT, liver transplantation; DDLT, deceased donor LT; RT, radiotherapy; mTORi, mammalian target of rapamycin inhibitor; HBIG, HB immunoglobulin.
